Resistance Mechanism of PD-1/PD-L1 Blockade in the Cancer-Immunity Cycle

Overview of attention for article published in OncoTargets and therapy, January 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 41 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

ANTI-PD1 THERAPY BASED ON RESPONSE TO IFN-I STIMULATION

Application WO-2023060361-A1

World Intellectual Property Organisation (WIPO)